{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T12:35:15Z","timestamp":1793968515805,"version":"4.8.0"},"reference-count":69,"publisher":"SAGE Publications","issue":"5","license":[{"start":{"date-parts":[[2013,10,28]],"date-time":"2013-10-28T00:00:00Z","timestamp":1382918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["J Oncol Pharm Pract"],"published-print":{"date-parts":[[2014,10]]},"abstract":"<jats:p>Intraperitoneal chemotherapy, involving the administration of certain chemotherapeutic agents directly to the intraperitoneal cavity, was developed as a novel therapeutic strategy early in the 1950s. Intraperitoneal administration of chemotherapy results in higher intraperitoneal concentration of the cytotoxic medications and minimal systemic exposure than observed with intravenous administration, which in turn may increase the efficacy of these agents with substantial reduction in systemic toxicity. Intraperitoneal chemotherapy was used successfully in peritoneal surface malignancies, including malignant peritoneal mesothelioma, pseudomyxoma peritonei, malignant ascites, sarcomatosis, and peritoneal carcinomatosis from gastrointestinal and ovarian cancers. Pharmacists may play a major role in optimizing intraperitoneal chemotherapy through verification of chemotherapy order for proper doses, dilution, preparation, and administration. Moreover, pharmacists are medication experts who can provide other health care professionals with the necessary drug information.<\/jats:p>\n                  <jats:p>Despite the local application of chemotherapy, intraperitoneal chemotherapy is not free of systemic side effects and can be associated with serious complications. The benefits of intraperitoneal chemotherapy should be weighed against its potential harm to maximize efficacy and to minimize morbidity and mortality as much as possible. The aim of this article is to review the current available literature regarding the safety and efficacy of intraperitoneal chemotherapy in cancer treatment.<\/jats:p>","DOI":"10.1177\/1078155213506244","type":"journal-article","created":{"date-parts":[[2013,10,28]],"date-time":"2013-10-28T22:34:22Z","timestamp":1382999662000},"page":"369-380","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":19,"title":["Intraperitoneal chemotherapy: Rationale, applications, and limitations"],"prefix":"10.1177","volume":"20","author":[{"given":"Osama M","family":"Al-Quteimat","sequence":"first","affiliation":[{"name":"Pharmaceutical Care Department, King Abdullah Medical City, Makkah, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariam A","family":"Al-Badaineh","sequence":"additional","affiliation":[{"name":"Pharmaceutical Care Department, King Abdullah Medical City, Makkah, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2013,10,28]]},"reference":[{"key":"bibr1-1078155213506244","first-page":"165","volume":"169","author":"Maurie Markman MD","year":"2009","journal-title":"Recent Res Cancer Res"},{"key":"bibr2-1078155213506244","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdl267"},{"key":"bibr3-1078155213506244","doi-asserted-by":"publisher","DOI":"10.4251\/wjgo.v2.i1.9"},{"key":"bibr4-1078155213506244","first-page":"299","volume":"3","author":"Goldstein P","year":"2005","journal-title":"Cancer Ther"},{"key":"bibr5-1078155213506244","doi-asserted-by":"publisher","DOI":"10.4251\/wjgo.v2.i2.68"},{"key":"bibr6-1078155213506244","doi-asserted-by":"publisher","DOI":"10.1016\/S1040-8428(99)00017-7"},{"key":"bibr7-1078155213506244","first-page":"Art. No. CD0053","volume":"11","author":"Jaaback K","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"bibr8-1078155213506244","doi-asserted-by":"crossref","unstructured":"Tentes AAK, Spiliotis ID, Korakianitis OS, et al. Adjuvant perioperative intraperitoneal chemotherapy in locally advanced colorectal carcinoma: Preliminary results\n                      . ISRN Surgery\n                      2011; article ID 529876, 6pp. DOI: 10.5402\/2011\/529876.","DOI":"10.5402\/2011\/529876"},{"key":"bibr9-1078155213506244","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/00003086-199101000-00002","volume":"262","author":"Coley WB","year":"1991","journal-title":"Clin Orthop Relat Res"},{"key":"bibr10-1078155213506244","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v16.i11.1299"},{"key":"bibr11-1078155213506244","doi-asserted-by":"publisher","DOI":"10.1097\/IGC.0b013e31821ee777"},{"key":"bibr12-1078155213506244","doi-asserted-by":"publisher","DOI":"10.1111\/IGC.0b013e3181b33d5b"},{"key":"bibr13-1078155213506244","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdr301"},{"key":"bibr14-1078155213506244","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7819-9-169"},{"key":"bibr15-1078155213506244","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-006-9167-9"},{"key":"bibr16-1078155213506244","doi-asserted-by":"publisher","DOI":"10.1016\/S1055-3207(03)00028-0"},{"key":"bibr17-1078155213506244","doi-asserted-by":"publisher","DOI":"10.4172\/2161-1076.1000125"},{"key":"bibr18-1078155213506244","doi-asserted-by":"crossref","unstructured":"Fung-Kee-Fung M, Provencher D, Rosen B, et al. Intraperitoneal chemotherapy for patients with advanced ovarian cancer: A review of the evidence and standards for the delivery of care.\n                      Gynecol Oncol\n                      Epub ahead of print 2007. DOI: 10.1016\/j.ygyno.2007.02.015.","DOI":"10.1016\/j.ygyno.2007.02.015"},{"key":"bibr19-1078155213506244","unstructured":"BCCA.\n                      Clinical pharmacy guide: Chemotherapy assessment and review\n                      . 3rd ed. Available at: http:\/\/www.bccancer.bc.ca\/HPI\/Pharmacy\/GuidesManuals\/PharmacyGuideChemo\/default.htm (2001)."},{"key":"bibr20-1078155213506244","doi-asserted-by":"publisher","DOI":"10.4251\/wjgo.v2.i2.109"},{"key":"bibr21-1078155213506244","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdf019"},{"key":"bibr22-1078155213506244","first-page":"413","volume":"4","author":"Chan DL","year":"2012","journal-title":"Cancer Manage Res"},{"key":"bibr23-1078155213506244","doi-asserted-by":"publisher","DOI":"10.1016\/S1055-3207(03)00038-3"},{"key":"bibr24-1078155213506244","first-page":"39","volume":"169","author":"de Bree E","year":"2007","journal-title":"Recent Res Cancer Res"},{"key":"bibr25-1078155213506244","first-page":"53","volume":"169","author":"de Bree E","year":"2007","journal-title":"Recent Res Cancer Res"},{"key":"bibr26-1078155213506244","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.10-2-112"},{"key":"bibr27-1078155213506244","doi-asserted-by":"publisher","DOI":"10.1200\/JOP.0858503"},{"key":"bibr28-1078155213506244","doi-asserted-by":"crossref","unstructured":"Sugarbaker PH, Stuart OA and Bijelic L. Intraperitoneal gemcitabine chemotherapy treatment for patients with resected pancreatic cancer: Rationale and report of early data.\n                      Int J Surg Oncol\n                      Epub ahead of print 2011; 2011. DOI: 10.1155\/2011\/161862.","DOI":"10.1155\/2011\/161862"},{"key":"bibr29-1078155213506244","doi-asserted-by":"publisher","DOI":"10.1007\/BF02557372"},{"key":"bibr30-1078155213506244","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2006.03.019"},{"key":"bibr31-1078155213506244","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2008-0275"},{"key":"bibr32-1078155213506244","unstructured":"NCCN. Clinical practice guideline for ovarian cancer. Version 1. Available online at: http:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/ovarian.pdf (2013)."},{"key":"bibr33-1078155213506244","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.05.2456"},{"key":"bibr34-1078155213506244","first-page":"Art. No. CD0053","volume":"11","author":"Jaaback K","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"bibr35-1078155213506244","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa052985"},{"key":"bibr36-1078155213506244","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2168.1998.00882.x"},{"key":"bibr37-1078155213506244","doi-asserted-by":"publisher","DOI":"10.4251\/wjgo.v2.i1.44"},{"key":"bibr38-1078155213506244","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.39.7166"},{"key":"bibr39-1078155213506244","doi-asserted-by":"publisher","DOI":"10.1007\/s10434-006-9708-2"},{"key":"bibr40-1078155213506244","unstructured":"BCCA. Protocol summary for the chemotherapy of pseudomyxoma peritonei using intraperitoneal mitomycin and fluorouracil. Available online at: http:\/\/www.bccancer.bc.ca\/NR\/rdonlyres\/C0A8933B-3AAD-4EBA-A95C-4552A0A060C9\/45092\/GIFUIP_Protocol_1May2010.pdf (2010)."},{"key":"bibr41-1078155213506244","first-page":"3353","volume":"29","author":"Woopen H","year":"2009","journal-title":"Anticancer Res"},{"key":"bibr42-1078155213506244","doi-asserted-by":"publisher","DOI":"10.1016\/S1055-3207(03)00050-4"},{"key":"bibr43-1078155213506244","first-page":"137","volume":"63","author":"Loggie BW","year":"1997","journal-title":"Am Surg"},{"key":"bibr44-1078155213506244","first-page":"2420","volume":"56","author":"Bitran JD","year":"1985","journal-title":"Pharmacokinetics and results of a phase II trial. Cancer"},{"key":"bibr45-1078155213506244","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2006.03.014"},{"key":"bibr46-1078155213506244","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.25423"},{"key":"bibr47-1078155213506244","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.24.8500"},{"key":"bibr48-1078155213506244","doi-asserted-by":"publisher","DOI":"10.1002\/jso.20676"},{"key":"bibr49-1078155213506244","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.04.187"},{"key":"bibr50-1078155213506244","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-008-9966-2"},{"key":"bibr51-1078155213506244","unstructured":"NCCN. Clinical practice guideline for colon cancer. Version 3. Available online at: http:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/colon.pdf (2013)."},{"issue":"1","key":"bibr52-1078155213506244","first-page":"49","volume":"59","author":"Radulescu C","year":"2009","journal-title":"TMJ"},{"key":"bibr53-1078155213506244","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-007-9487-4"},{"key":"bibr54-1078155213506244","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-12-526"},{"key":"bibr55-1078155213506244","doi-asserted-by":"publisher","DOI":"10.1186\/1479-5876-4-17"},{"key":"bibr56-1078155213506244","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdl428"},{"key":"bibr57-1078155213506244","doi-asserted-by":"publisher","DOI":"10.1016\/S0399-8320(07)73964-7"},{"key":"bibr58-1078155213506244","doi-asserted-by":"publisher","DOI":"10.1016\/S1055-3207(03)00045-0"},{"key":"bibr59-1078155213506244","first-page":"195","volume":"134","author":"Ceelen WP","year":"2007","journal-title":"Cancer Treat Res"},{"key":"bibr60-1078155213506244","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.04.150"},{"key":"bibr61-1078155213506244","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.23.9640"},{"key":"bibr62-1078155213506244","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-007-0647-9"},{"key":"bibr63-1078155213506244","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.09.3907"},{"key":"bibr64-1078155213506244","doi-asserted-by":"publisher","DOI":"10.1016\/S0959-8049(98)00375-X"},{"issue":"1","key":"bibr65-1078155213506244","first-page":"20","volume":"16","author":"de Bree E","year":"2003","journal-title":"Ann Gastroenterol"},{"key":"bibr66-1078155213506244","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199612263352603"},{"key":"bibr67-1078155213506244","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-006-9186-6"},{"key":"bibr68-1078155213506244","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-199809000-00007"},{"key":"bibr69-1078155213506244","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejon.2012.10.005"}],"container-title":["Journal of Oncology Pharmacy Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1078155213506244","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/1078155213506244","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1078155213506244","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T02:15:09Z","timestamp":1777688109000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/1078155213506244"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10,28]]},"references-count":69,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["10.1177\/1078155213506244"],"URL":"https:\/\/doi.org\/10.1177\/1078155213506244","relation":{},"ISSN":["1078-1552","1477-092X"],"issn-type":[{"value":"1078-1552","type":"print"},{"value":"1477-092X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,10,28]]}}}